Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Outcomes of Clinical Trials on the Roles of Immune Checkpoint Inhibitors in the Management of Lung Cancers: A Comprehensive Review

2025Premier journal of science.JournalOpen access

10.70389/pjs.100084 Full text0 citations

Authors

9 authors across 5 institutions in 2 countries.

Saheed SanyaoluFirst authorCorresponding
- Olabisi Onabanjo University (NG)
as printed: Saheed E. Sanyaolu
Maryam O. Adebayo
- University of Ibadan (NG)
Maryam O. Adebayo
- University of Ibadan (NG)
Oluwaseun O. Adekoya
Oluwaseun O. Adekoya
Halimah O. Alao
- University of Ilorin (NG)
Halimah O. Alao
- University of Ilorin (NG)
Fadilulahi A. UsmanSenior author
- Nigerian Institute of Medical Research (NG)
Fadilulahi A. UsmanSenior author
- Nigerian Institute of Medical Research (NG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Lung Cancer Research Studieslevel 3 · 1.00
Cancer Immunotherapy and Biomarkerslevel 3 · 1.00
Peptidase Inhibition and Analysislevel 3 · 1.00

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2025 · Premier journal of science. · 0 citations
https://openalex.org/W4411475146

Outcomes of Clinical Trials on the Roles of Immune Checkpoint Inhibitors in the Management of Lung Cancers: A Comprehensive Review · Sankore